Unresectable Laryngeal Squamous Cell Carcinoma: Clinical Trials

2 trials for Unresectable Laryngeal Squamous Cell Carcinoma, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 active not recruiting, 1 recruiting. 2 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 12Active not recruiting 1, Recruiting 1

Follow Unresectable Laryngeal Squamous Cell Carcinoma: new trials by email Literature Review of Unresectable Laryngeal Squamous Cell Carcinoma trials Research Report on Unresectable Laryngeal Squamous Cell Carcinoma

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Testing the Addition of an Anti-Cancer Drug, Camonsertib, to Radiation Therapy for Recurrent Head and Neck Squamous Cell Carcinoma
Biospecimen Collection, Camonsertib, Computed Tomography - Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, Recurrent Head and Neck Squamous Cell Carcinoma
Phase 1RecruitingNational Cancer Institute (NCI)392027-02-132026-09-03
Testing the Addition of an Anti-cancer Drug, BAY 1895344, With Radiation Therapy to the Usual Pembrolizumab Treatment for Recurrent Head and Neck Cancer
Biospecimen Collection, Computed Tomography, Elimusertib - Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, Clinical Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8
Phase 1Active not recruitingNational Cancer Institute (NCI)72022-07-062026-08-21

Narrower conditions

Carcinoma (2)  ·  Hypopharyngeal Neoplasms (2)  ·  Laryngeal Neoplasms (2)  ·  Mouth Neoplasms (2)  ·  Oropharyngeal Neoplasms (2)  ·  Squamous Cell Carcinoma of Head and Neck (2)  ·  Salivary Gland Neoplasms (1)

Broader conditions

Carcinoma, Squamous Cell (2)  ·  Head and Neck Neoplasms (2)  ·  Laryngeal Diseases (2)  ·  Mouth Diseases (2)  ·  Neoplasms (2)  ·  Neoplasms by Histologic Type (2)  ·  Neoplasms by Site (2)  ·  Neoplasms, Glandular and Epithelial (2)  ·  Otorhinolaryngologic Diseases (2)  ·  Otorhinolaryngologic Neoplasms (2)  ·  Pharyngeal Diseases (2)  ·  Pharyngeal Neoplasms (2)  ·  Respiratory Tract Diseases (2)  ·  Respiratory Tract Neoplasms (2)  ·  Stomatognathic Diseases (2)

Interventions

Magnetic Resonance Spectroscopy (2)  ·  Radiosurgery (2)  ·  Specimen Handling (2)  ·  BAY 1895344 (1)  ·  pembrolizumab (1)

Sponsors

National Cancer Institute (NCI) (2)

Countries

United States (2)

Top investigators

Yvonne M Mowery (2)

NIH funding

UM1CA186690 (2)